BPMC

Blueprint Medicines

Delisted

BPMC was delisted on the 17th of July, 2025.

219 hedge funds and large institutions have $3.78B invested in Blueprint Medicines in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 87 increasing their positions, 56 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

0% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 29

0% less funds holding

Funds holding: 220219 (-1)

19% less capital invested

Capital invested by funds: $4.68B → $3.78B (-$898M)

Holders
219
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$90.8M
Puts
$29.4M
Net Calls
Net Calls Change

Top Buyers

1 +$65.8M
2 +$18.4M
3 +$17.2M
4
HM
HealthCor Management
New York
+$16.7M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.5M

Top Sellers

1 -$24.2M
2 -$23.8M
3 -$20.7M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$17.9M
5
AG
Artal Group
Luxembourg
-$11M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$540M
2
$319M
3
$316M
4
$265M
5
$184M
6
$135M
7
$112M
8
$110M
9
$104M
10
$78.1M
11
$73.9M
12
$69.1M
13
$64.9M
14
$62.4M
15
$62.2M
16
$58.9M
17
$56.4M
18
$53.8M
19
$48.6M
20
$47.5M
21
$46.9M
22
$44.8M
23
$44.1M
24
$41.6M
25
$41.1M